A previous study used pharmacogenomics and molecular docking approaches to supplementary show epidermal growth factor receptor (EGFR)-transfected tumor cells were collaterally sensitive to honokiol compared with wild type cells [8]. The gene discussed is EGFR; the disease is neoplasm.